Researchers design a drug capable of acting simultaneously against three different therapeutic targets
A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new ...
GuelphToday1h
The 'Godfather of AI' joins list of distinguished Canadians who have won Nobel Prize
Geoffrey Hinton was awarded a Nobel Prize in physics on Tuesday in recognition of his trailblazing contributions to the field ...
Neurology Advisor3h
Zilganersen Fast Tracked for Patients With Alexander Disease
The FDA has granted Fast Track designation to zilganersen for the treatment of Alexander disease, a rare type of leukodystrophy.
FierceBiotech3h
City Therapeutics breaks ground with $135M and blueprints from RNAi expert John Maraganore
A new RNAi biotech is breaking ground with $135 million and John Maraganore, Ph.D., holding the key to the city. | A new RNAi ...
PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...
PharmiWeb8h
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present preclinical data for its proprietary Axiomer™ ...
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now
Moreover, CBS reported that Hurricane Helene is projected to be one of the most expensive storms in U.S. history, with ...